MHRA and FDA Launch Unique Liaison Programme to Strengthen Regulatory Collaboration

16th June 2026

Summary: The MHRA and the United States Food and Drug Administration (FDA) have announced a new liaison programme designed to strengthen collaboration between the two regulators. The initiative will enable staff from each organisation to work more closely together, sharing expertise, regulatory knowledge and best practice across areas including medicines, medical devices and emerging technologies. By improving communication and mutual understanding of regulatory approaches, the programme aims to support more efficient decision-making, encourage innovation and help accelerate patient access to safe and effective healthcare products. The collaboration builds on an already strong relationship between the MHRA and FDA and reflects a shared commitment to advancing regulatory science while maintaining high standards of patient safety and public health.

Link: https://www.gov.uk/government/news/unique-liaison-programme-set-to-reinforce-close-collaboration-between-mhra-and-fda

Back to Recent News